![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 31110 |
FusionGeneSummary for RGS17_PDLIM5 |
![]() |
Fusion gene information | Fusion gene name: RGS17_PDLIM5 | Fusion gene ID: 31110 | Hgene | Tgene | Gene symbol | RGS17 | PDLIM5 | Gene ID | 26575 | 10611 |
Gene name | regulator of G protein signaling 17 | PDZ and LIM domain 5 | |
Synonyms | RGS-17|RGSZ2|hRGS17 | ENH|ENH1|L9|LIM | |
Cytomap | 6q25.2 | 4q22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | regulator of G-protein signaling 17 | PDZ and LIM domain protein 5enigma homologenigma-like LIM domain proteinenigma-like PDZ and LIM domains protein | |
Modification date | 20180519 | 20180522 | |
UniProtAcc | Q9UGC6 | Q96HC4 | |
Ensembl transtripts involved in fusion gene | ENST00000367225, ENST00000206262, | ENST00000450793, ENST00000538141, ENST00000380180, ENST00000318007, ENST00000437932, ENST00000317968, ENST00000542407, ENST00000508216, ENST00000514743, ENST00000380176, ENST00000359265, ENST00000512274, ENST00000504489, | |
Fusion gene scores | * DoF score | 4 X 3 X 3=36 | 9 X 12 X 5=540 |
# samples | 4 | 12 | |
** MAII score | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(12/540*10)=-2.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: RGS17 [Title/Abstract] AND PDLIM5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | SARC | TCGA-DX-A6YQ-01A | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000367225 | ENST00000450793 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000538141 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000380180 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000318007 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000437932 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000317968 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000542407 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000508216 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000514743 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-3UTR | ENST00000367225 | ENST00000380176 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000359265 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000512274 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000367225 | ENST00000504489 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000450793 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000538141 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000380180 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000318007 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000437932 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000317968 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000542407 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000508216 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000514743 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-3UTR | ENST00000206262 | ENST00000380176 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000359265 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000512274 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
5CDS-intron | ENST00000206262 | ENST00000504489 | RGS17 | chr6 | 153365035 | - | PDLIM5 | chr4 | 95583573 | + |
Top |
FusionProtFeatures for RGS17_PDLIM5 |
![]() |
Hgene | Tgene |
RGS17 | PDLIM5 |
Regulates G protein-coupled receptor signaling cascades,including signaling via muscarinic acetylcholine receptor CHRM2and dopamine receptor DRD2. Inhibits signal transduction byincreasing the GTPase activity of G protein alpha subunits,thereby driving them into their inactive GDP-bound form(PubMed:15096504). Binds selectively to GNAZ and GNAI2 subunits,accelerates their GTPase activity and regulates their signalingactivities. Negatively regulates mu-opioid receptor-mediatedactivation of the G-proteins (By similarity).{ECO:0000250|UniProtKB:Q9QZB0, ECO:0000269|PubMed:15096504}. | May play an important role in the heart development byscaffolding PKC to the Z-disk region. May play a role in theregulation of cardiomyocyte expansion. Overexpression promotes thedevelopment of heart hypertrophy. Contributes to the regulation ofdendritic spine morphogenesis in neurons. May restrainpostsynaptic growth of excitatory synapses (By similarity).{ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for RGS17_PDLIM5 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for RGS17_PDLIM5 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
RGS17 | OSTM1, RBBP8, RABEP1, ADRB2, AQP1, GNAI1, GNAI3, HOXA1, SMCP, RPL10A, OTX1, PTGER3, NUFIP2, DHX37, TBC1D16, LCE4A, LCE2A, LCE3C | PDLIM5 | TRIM39, CACNA1B, PRKCB, PRKCE, GFI1B, NDUFA7, SIN3A, ELMSAN1, DSTN, FN1, CALU, EIF4A3, METTL1, NPLOC4, PDE12, ANP32A, CBS, IPO11, PKM, PLIN3, SRP14, UBA2, RAD23B, TPD52, ZYX, COIL, CCDC136, KRT40, KRTAP10-7, SUZ12, RNF2, BMI1, SIRT6, ILK, METTL6, RWDD2B, SYT11, DNAJC8, MAP2K1, MAP2K2, ARFIP2, CAMK2G, NTRK1, BTRC, MED4, SSX2IP, CEP128, CEP19, XPO1, CDH1, PDLIM7, TULP3, PHF19, NFATC2IP, DENR, TPM2, EMILIN1, ATG14, G3BP1, BRCA1, TES |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RGS17_PDLIM5 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for RGS17_PDLIM5 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | RGS17 | C0024809 | Marijuana Abuse | 1 | PSYGENET |
Hgene | RGS17 | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |
Tgene | PDLIM5 | C0005586 | Bipolar Disorder | 5 | PSYGENET |
Tgene | PDLIM5 | C0036341 | Schizophrenia | 4 | PSYGENET |
Tgene | PDLIM5 | C0041696 | Unipolar Depression | 4 | PSYGENET |
Tgene | PDLIM5 | C1269683 | Major Depressive Disorder | 4 | PSYGENET |
Tgene | PDLIM5 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Tgene | PDLIM5 | C0221765 | Chronic schizophrenia | 1 | PSYGENET |